Analyze Diet

Cardiovascular and respiratory effects of detomidine in isoflurane-anaesthetised horses.

Abstract: Anaesthesia was induced in horses (n = 6) with a mixture of thiopentone and guaiphenesin and maintained by mechanical ventilation with a mixture of oxygen, air and isoflurane. Inspiratory and end-expiratory concentrations of oxygen, carbon dioxide and isoflurane were measured. Electrocardiography was used to evaluate heart rate and rhythm. Mean systemic arterial pressure (SAPm), pulmonary artery pressure (PAPm), right atrial pressure (RAPm) and pulmonary capillary wedge pressure (PCWP) were measured directly. Cardiac output was determined using the thermodilution method. Microcirculation in the upper triceps brachii muscle was estimated using laser Doppler flowmetry. Blood gas values, pH and haemoglobin concentration (Hb) were determined in arterial and mixed venous blood. Baseline values were taken after stabilisation of anaesthesia and were statistically compared to values obtained after an intravenous bolus of detomidine (10 micrograms/kg) had been injected at Time 0. Samples were then collected at 2, 10, 20, 30, 40 and 50 min. End-expiratory concentration of isoflurane was maintained at 1.8% during the experimental period described above. Thereafter, the isoflurane concentration was reduced to 1.3% and samples were collected at 60, 70 and 80 min. Detomidine caused a significant reduction of heart rate (HR), cardiac index (CI), oxygen transport (O2TR) and a significant elevation of the SAPm, systemic vascular resistance (SVR) and coefficient of utilisation of oxygen (O2CU) at 2 min. A significant reduction in HR, CI, SAPm, Hb, content of oxygen in arterial blood (CaO2) and O2TR and a significant elevation of O2CU were observed 10-50 min after the injection of detomidine. Reduction of the isoflurane end-expiratory concentration to 1.3% was followed by a progressive improvement of the SAPm, CI and muscle perfusion towards the baseline values. Further reduction of Hb and CaO2 as compared to the baseline values was observed during the period. The data suggest that detomidine potentiates some of the cardiovascular effects of isoflurane in horses.
Publication Date: 1996-12-01 PubMed ID: 9284031
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the cardiovascular and respiratory effects of administering detomidine to isoflurane-anesthetized horses. It found that detomidine changes several heart and respiration measures, and it suggests that detomidine enhances some of the cardiovascular effects of isoflurane.

Research Methodology

  • The research was conducted on six horses. Anaesthesia was induced in these horses using a mixture of thiopentone and guaiphenesin and maintained by breathing a mix of oxygen, air, and isoflurane.
  • Using electrocardiography, the researchers evaluated the heart rate and rhythm of the horses. They also directly measured mean systemic arterial pressure (SAPm), pulmonary artery pressure (PAPm), right atrial pressure (RAPm), and pulmonary capillary wedge pressure (PCWP).
  • They estimated the blood flow in the upper triceps brachii muscle using a process called laser Doppler flowmetry.
  • They checked the blood gas values, pH, and haemoglobin concentration (Hb) in arterial and mixed venous blood.
  • A baseline was established after stabilising anaesthesia and the results obtained were statistically compared with those observed after an intravenous bolus of detomidine had been administered. Samples were taken at intervals from 2 to 80 minutes post-injection.

Research Findings

  • The data revealed that administering detomidine caused significant reductions in heart rate (HR), cardiac index (CI), and oxygen transport (O2TR). It also led to a significant increase in SAPm, systemic vascular resistance (SVR), and the utilization efficiency of oxygen (O2CU) after 2 minutes.
  • Additionally, a significant decline in HR, CI, SAPm, Hb, and the content of oxygen in arterial blood (CaO2), alongside a significant increase in O2CU, were noticed 10-50 minutes after detomidine was given.
  • Reducing the end-expiratory concentration of isoflurane to 1.3% led to a progressive improvement in SAPm, CI, and muscle perfusion back towards the baseline. In comparison, there was a further decrease in Hb and CaO2 against the baseline values.

Conclusion

  • The research findings suggest that detomidine has the capacity to increase some of the cardiovascular effects of isoflurane in horses. This provides a deeper understanding of the combined impact of detomidine and isoflurane, which could potentially enhance the safety and efficacy of anaesthesia practices in veterinary medicine, especially with horses.

Cite This Article

APA
Still J, Serteyn D, van der Merwe CA. (1996). Cardiovascular and respiratory effects of detomidine in isoflurane-anaesthetised horses. J S Afr Vet Assoc, 67(4), 199-203.

Publication

ISSN: 1019-9128
NlmUniqueID: 7503122
Country: South Africa
Language: English
Volume: 67
Issue: 4
Pages: 199-203

Researcher Affiliations

Still, J
  • Department of Companion Animal Medicine and Surgery, Faculty of Veterinary Science, Medical University of Southern Africa, Medunsa, South Africa.
Serteyn, D
    van der Merwe, C A

      MeSH Terms

      • Adrenergic alpha-Agonists / pharmacology
      • Analgesics / pharmacology
      • Anesthetics, Inhalation / pharmacology
      • Animals
      • Blood Gas Analysis / veterinary
      • Cardiovascular System / drug effects
      • Female
      • Hemoglobins / analysis
      • Hemoglobins / drug effects
      • Horses / physiology
      • Imidazoles / pharmacology
      • Isoflurane / pharmacology
      • Oxygen / blood
      • Oxygen Consumption / drug effects
      • Respiration / drug effects
      • Time Factors

      Citations

      This article has been cited 0 times.